Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization

Molecular Diagnosis

Volumn 8, Issue 2, 2004, Pages 93-100

  Scaruffi, Paola ^a,b   Parodi, Stefano ^a   Mazzocco, Katia ^b   Defferrari, Raffaella ^b   Fontana, Vincenzo ^a   Bonassi, Stefano ^a   Tonini, Gian Paolo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Italian Neuroblastoma Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; MOLECULAR MARKER;

ACCURACY; ARTICLE; CHROMOSOME 12P; CHROMOSOME 1P; CHROMOSOME 2Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PURIFICATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLAST; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PROGNOSIS;

CELL NUCLEUS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; FLUORESCENT DYES; GENE AMPLIFICATION; GENETIC MARKERS; HUMANS; INDOLES; NEUROBLASTOMA; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; PROGNOSIS;

EID: 5444251799     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.2165/00066982-200408020-00003     Document Type: Article

References (35)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-16
2. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-MYC in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121-4
3. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111-6
4. White PS, Maris JM, Beltinger C, et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A 1995; 92: 5520-4
5. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996; 334: 225-30
6. Tonini GP, Boni L, Pession A, et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol 1997; 15: 85-93
7. Ambros IM, Benard J, Boavida M, et al. Quality assessment of genetic markers used for therapy stratification. J Clin Oncol 2003; 21: 2077-84
8. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003; 63: 2872-80
9. Bruder CE, Hirvela C, Tapia-Paez I, et al. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 2001; 10: 271-82
10. Hui AB, Lo KW, Yin XL, et al. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 2001; 81: 717-23
11. Takeo S, Arai H, Kusano N, et al. Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet 2001; 130: 127-32
12. Wilhelm M, Veltman JA, Olshen AB, et al. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 2002; 62: 957-60
13. Clark J, Edwards S, John M, et al. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes Chromosomes Cancer 2002; 34: 104-14
14. Seo MY, Rha SY, Yang SH, et al. The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. Int J Mol Med 2004; 13: 17-24
15. Arai H, Ueno T, Tangoku A, et al. Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet 2003; 146: 16-21
16. Clark J, Edwards S, Feber A, et al. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene 2003; 22: 1247-52
17. Wessendorf S, Schwaenen C, Kohlhammer H, et al. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 2003; 22: 1425-9
18. Squire JA, Pei J, Marrano P, et al. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 2003; 38: 215-25
19. Tong CY, Hui AB, Yin XL, et al. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg 2004; 100: 187-93
20. Schwaenen C, Nessling M, Wessendorf S, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci U S A 2004; 101: 1039-44
21. Beheshti B, Braude I, Marrano P, et al. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 2003; 5: 53-62
22. Ambros PF, Ambros IM, and the SIOP Europe Neuroblastoma Pathology, et al. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol. 2001 Dec; 37 (6): 492-504
23. Shimada H, Ambros IM, Dehner LP, et al. The international neuroblastoma pathology classification (the Shimada system). Cancer 1999; 86: 364-72
24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989
25. I.M.A.G.E. Consortium [online]. Available from URL: http://image.llnl. gov/ [Accessed 2004 Jul 28]
26. NCBI UniGene [online]. Available from URL: http://www.ncbi.nlm.nih.gov/ UniGene [Accessed 2004 July 20]
27. Lo Cunsolo C, Iolascon A, Cavazzana A, et al. Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development. Cancer Genet Cytogenet 1999; 109: 126-30
28. Peter M, Michon J, Vielh P, et al. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int J Cancer 1992; 52: 544-8
29. Schena M. Microarray analysis. New York: J Wiley & Sons Press, 2003
30. Nadon R, Shoemaker J. Statistical issues with microarrays: processing and analysis. Trends Genet 2002; 18: 265-71
31. Shoemaker DD, Linsley PS. Recent developments in DNA microarrays. Curr Opin Microbiol 2002; 5: 334-7
32. Ambros PF, Ambros IM, Kerbl R, et al. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001; 36: 1-4
33. Takeda O, Homma C, Maseki N, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 1994; 10: 30-9
34. Iolascon A, Lo Cunsolo C, Giordani L, et al. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavorable outcome. Cancer Lett 1998; 130: 83-92
35. Solinas-Toldo S, Lampel S, Stilgenbauer S, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997; 20: 399-407